As of mid-2025, retatrutide remains in clinical trials and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
VITAMIN C Promotes healthy ageing, as it contributes to the defence system, acting as an antioxidant and an enzyme for essential growth and tissue repair of cells
Potential Benefits and Limitations of Using GLP-1 for IBS For IBS patients who are overweight or have comorbid type 2 diabetes, GLP-1 medications offer a dual-benefit approach: addressing both metabolic health and gastrointestinal dysfunction simultaneously
Galter D, Mihm S, Droge W
Patients must disclose complete medical history, current medications, and follow all prescribed protocols for safe and effective treatment outcomes
March 8, 2024 156.122 Prescription drug benefits. ecfr.gov